Interactions in anesthesia: Anesthetic management of the drug abusing parturient

Acta Anaesthesiologica Belgica

Volumn 52, Issue 4, 2001, Pages 351-356

  Birnbach, D J ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; COCAINE; ILLICIT DRUG; OPIATE;

ANESTHESIOLOGICAL TECHNIQUES; CONFERENCE PAPER; DRUG ABUSE; DRUG MECHANISM; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; PERINATAL CARE; PREGNANCY COMPLICATION; SUBSTANCE ABUSE;

ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; ANESTHESIA, OBSTETRICAL; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE-RELATED DISORDERS;

EID: 0035672469     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida
2. Characteristics of pregnant substance abusers in two cities in the northeast
3. Prevalence of use of cocaine and other substances in an obstetric population
4. Recognizing illicit drug use by pregnant women: Reports from Oregon birth attendants
5. Reproductive risks of cocaine
6. Substance abuse and HIV in pregnancy
7. Cocaine using during pregnancy and low birth weight, the impact of prenatal care and drug treatment
8. Effects of maternal marijuana and cocaine use on fetal growth
9. Substance abuse in pregnancy, Symposium on Women's Healthcare
10. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
11. Cocaine use during pregnancy, prevalence and correlates
12. Pharmacology and therapeutic applications of cocaine
13. Preterm premature rupture of membranes associated with recent cocaine use
14. Cocaine abuse in the parturient and effects on the fetus and neonate
15. Incidence of intrauterine cocaine exposure in a suburban setting
16. Development of a therapeutic vaccine for the treatment of cocaine addiction
17. Cocaine use during pregnancy, adverse perinatal outcome
18. Spontaneous pneumothorax following cocaine use in pregnancy
19. Uterine rupture in association with alkaloidal cocaine use
20. Cocaine abuse during pregnancy, maternal and fetal implications
21. Pregnancy increases cardiovascular toxicity to cocaine
22. Human placenta as a target organ for cocaine action, interaction of cocaine with the placental serotonin transporter
23. Patterns of cocaine bingeing, effect on pregnancy
24. Maternal and fetal medicine number 114
25. Cocaine screening of parturients without prenatal care, an evaluation of a rapid screening assay
26. Cocaine-abusing parturients undergoing cesarean section. A cohort study
27. Cocaine abuse in the parturient, what are the anesthetic implications
28. Propranolol induced hypertension in the treatment of cocaine intoxication
29. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade
30. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe
31. Cocaine induced hypertension in the ewe and response to treatment with labetalol
32. The management of cocaine-associated myocardial ischemia
33. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats
34. Cardiovascular disease in the pregnant patient. A new risk factor
35. Cocaine toxicity and isoflurane anesthesia, hemodynamic, myocardial metabolic, and regional blood flow effects in swine
36. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse
37. Cocaine and succinylcholine sensitivity, a new caution
38. The substance-abusing parturient, implications for analgesia and anaesthesia management
39. Acid-base abnormalities associated with cocaine toxicity in emergency department patients
40. Nitroglycerin in the treatment of cocaine associated chest pain-clinical safety and efficacy
41. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction
42. Randomized double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes
43. Identification of polysubstance abuse in the parturient
44. Hazards to health, dextroamphetamine poisoning
45. Intracerebral hemorrhage and oral amphetamine
46. Amphetamine ingestion presenting as eclampsia
47. Cardiac arrest in a chronic amphetamine abuser
48. Amphetamine abuse and obstetrical anesthesia
49. Alteration of anesthetic requirement by amphetamine
50. Toxicity and deaths from 3, 4-methylenedioxymethamphetamine (ecstasy)
51. New drugs of abuse
52. Ecstasy intoxication, appreciation of complications and the role of dantrolene
53. Maternal and fetal effects of heroin addiction during pregnancy
54. Drug dependence and pregnancy, antenatal and intrapartum problems
55. Acute abstinence syndrome after epidural injection of butorphanol
56. Clonidine in acute opiate withdrawal
57. Anaesthesia and substance abuse
58. Alcohol use in pregnancy
59. Incidence of fetal alcohol syndrome and prevalence of alcohol related neurodevelopmental disorder
60. Anaesthesia and alcohol
61. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics
62. Prenatal exposure to tobacco and marijuana, effects during pregnancy, infancy, and early childhood
63. Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana
64. Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana
65. Maternal cannabis use and birth weight, a meta-analysis
66. Effects of maternal marijuana and cocaine on fetal growth
67. The impact of prenatal marijuana and cocaine use on the infant and child
68. Substance abuse during pregnancy
69. Early development of infants exposed to drugs perinatally